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 Current treatments for insulin dependent diabetes fall short of achieving the 
natural glycemic regulation of functional islets, resulting in the development of secondary 
complications.  A bioartificial pancreas, comprised of insulin-secreting cells encapsulated 
in a hydrogel, is a promising approach to treat insulin-dependent diabetes.  The cells 
would provide regulated insulin in response to elevated blood glucose levels, thereby 
providing superior glycemic regulation to exogenous insulin delivery.  Two of the curent 
challenges to the successful clinical application of a bioartificial pancreas are: 1) it does 
not ensure immune acceptance of xenogeneic cells and immunosuppression appears 
necessary and 2) the transplantation site of the bioartificial pancreas has been shown to be 
hypoxic compared to islet extraction area. 
 To address the first concern, this thesis tests the stability and insulin diffusivity to 
characterize an encapsulation material that is known to steric hindrance effects. This 
property can combat the adsorption of proteins to its surface, reducing failure of the graft 
by immune rejection. For the second concern, this experiment will look at total protein 
content, the ratio of insulin secretion to intracellular insulin content, and metabolic 
activity of encapsulated adult and neonatal porcine islets exposed to different oxygen 
levels. This will give insight to the effects of hypoxia on different functions of each islet 
type, and help determine which islet type is more preferred for transplantation in hypoxic 
regions.  
Researchers emphasize on the use of an alginate material for encapsulation 
because this material is water soluble and does not seem to interfere with cellular 
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functions, but is permeable to molecules that activate immune protein production. Then, 
poly(l-lyisine) (PLL) was used to lay on top of the alginate capsules to decrease the 
permeation of of the unwanted molecules, however, PLL stimulates an immune response 
by the host cells. Several considerations were made for a material to cover the PLL layer 
in order to improve immune acceptance, such as another layer of alginate. Alginate-PLL-
alginate (APA) beads were unsuccessful when the permeation of molecules through the 
outer alginate layer, made it unstable and exposed the PLL layer underneath. Now, 
research is concentrated on finding an encapsulation material to replace the outer layer of 
alginate to cover the PLL layer. Poly (ethylene glycol), or PEG, chemistry has been 
determined to be a strong candidate for encapsulation because it resists protein adsorption 
and host cell adhesion.  
 Using Ca-LVM as the alignate material, this study focuses on the bonding of PEG 
with Ca-LVM-PLL beads as a possible encapsulation material by characterizing its 
stability over a 35-day period and insulin diffusivity for one hour. To test the stability of 
the PEGylated coating, FITC tagged PEG was used to observe the density of the PEG on 
the Ca-LVM-PLL beads over time. The diffusivity of insulin was tested by monitoring 
insulin diffusion out of the capsules and into the bulk liquid. Experimental data from the 
insulin diffusivity test were fit to the analytical solution for Fickian diffusion to 
determine the effective diffusivity of insulin in each capsule type. Interestingly, the beads 
were found to be stable within the 35-day duration of the experiment, and the diffusivity 
of PEGylated beads were comparable to that of Ca-LVM and APA beads in already 
published data.  
 3 
 Encapsulated islets are transplanted into the peritoneal cavity, which has be 
shown to be hypoxic compared to the environment that the islets were extracted from. 
The second part of this thesis studied the effects of oxygen availability on the functions 
of islets of different ages and islets exposed to different levels of oxygen. Neonatal 
porcine islets were exposed to 1% and 10% at saturation (AS), and adult porcine islets 
were exposed to 10% AS; with a normoxic group (21% AS) for each islet group. 
Preliminary results showed that lower levels of oxygen has more effect on the functions 





 Diabetes is a metabolic disease in which a person has high blood sugar resulting 
from one of two ways: the pancreas not producing enough insulin to maintain normal 
blood sugar levels or insulin resistance. It is a major health problem that affects 
approximately 23.6 million people in the United States, 27% of which (about 6.4 million 
people) have become insulin-dependent. Without proper regulation, deviations from 




 The most common treatment for insulin dependent diabetes (IDD) patients 
involves self-monitoring their blood glucose level several times a day and self-injecting 
their bodies with insulin. This method does not continuously monitor blood glucose 
levels and thus, excursions from normoglycemia often occur without the patient’s 
knowledge. Current research focuses on developing a treatment method that works within 
the body of IDD patients and freely “senses” the amount of glucose in the blood as well 
as administers an appropriate amount of insulin needed to regulate glycemic levels.
2
  
 Cell-based insulin therapy remains a promising approach to alleviate glycemic 
monitoring and to provide more physiologic insulin delivery for IDD patients. The 
development of a successful bioartifical pancreas would not only reduce the patient’s 
regular monitoring, but also improve glycemic control, thus reducing the development of 
the long-term complications associated with diabetes. Researchers are currently 
investigating methods to produce a bioartificial pancreas which secretes insulin in 
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response to physiologic cues. The bioartificial pancreas is composed of encapsulated 
insulin-producing cells in a semi-permeable membrane. The encapsulated insulin-
producing cells will respond to the blood glucose levels and secrete insulin to regulate the 
glycemic levels. Successful membranes will allow the delivery of insulin to IDD patients 
and further protecting the cells after transplantation.
2
  
 The first major concern for the development of a bioartificial pancreas is that it 
does not ensure immune acceptance of xenogeneic cells and immunosuppression appears 
necessary.
2,3
 Suppressing the immune system increases the susceptibility to infectious 
disease and cancers. One way to reduce the need for immunosuppressants is refining the 
encapsulation material itself.
4
 The second major concern with the bioartificial pancreas 
development is that the transplantation site has been shown to be hypoxic compared to 
islet extraction area.
5 
The difference in oxygen availability may have effects on the 
function of the encapsulated islets. 
 The goal of this research is to develop a bioartifical pancreas that mimics the 
glycemic control of a non-diabetic patient and allow for the diffusion of insulin across the 
semi-permeable barrier to signal the body to absorb excess blood glucose. Current 
research is focused on using the alginate-poly(l-lysine) [AP] system as the semi-
permeable barrier for encapsulating the islets. Alginate is a water soluble polymer 
derived from alga that has been shown to not interfere with cellular function, but is 
permeable to immunoglobulin G (IgG), a molecule that can bind to the encapsulated cells 
and activate a cascade of immune protein production to eliminate foreign bodies, 
including the hydrogel.
6
 A layer of poly(l-lysine) [PLL] was added over the alginate 
hydrogel to resist the diffusion of IgG.
7
 However, PLL induces an immune response from 
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the host resulting in an adsorption of proteins, followed by host cell adhesion, and the 
formation of a fibrotic capsule to its surface, leading to insufficient nutrient exchange and 
cell death inside the capsules.
3,8,9 
 Researchers are forced to search for a stable alternative source for human islets 
due to the shortage of human donors. Although xenogeneic transplantation are 
immunogenic, islets derived from pigs are an attractive option because they reduce 
source limitations and regulate glucose levels in the same physiologic range as human 
islets.
10
 Both adult porcine islets (APIs) and neonatal porcine islets (NPIs) have been 
shown to restore glycemic control in diabetic animal models. Although NPIs are less 
difficult to isolate and possess a potential for growth, they require several weeks to 
function post-transplantation when compared to APIs but were found to be more resistant 
to hypoxia.
11,12
 Understanding the function of both types of cells under hypoxic 
conditions can aid in determining which type of islet is more suitable for transplantation. 
 Encapsulated islets are commonly transplanted in the peritoneal cavity of the 
abdomen. This area is wanted because it can accommodate a high volume, and the 
transplantation of the encapsulated cells at this site is done by a direct surgical procedure. 
The drawback is that this site has been shown to be hypoxic compared to the normal 
environment where the islets are extracted.
5
 Furthermore, the encapsulation method 
prevents neovascularization of the encapsulated islets, forcing cells to depend on 
diffusion to be supplied with oxygen and other nutrients.
13 
 The oxygen concentration of the transplantation sites the grafted islets or cells are 
distinctly below the arterial level [142 mm Hg].
5,12
 Continuous measurements of the 
oxygen partial pressure (pO2) in the peritoneum of rabbits were made in Spokane (1990). 
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They reported 43 ± 13 mm Hg for the intraperitoneal pO2 of rabbits breathing normal 
air.
14
 The pO2 in diffusion chambers contained 30 islets and implanted intraperitoneally 
in rats was 29 ± 12 μm Hg four weeks after implantation.
15
 The low levels of oxygen in 
the peritoneal cavity may affect the functions of the encapsulated cells. As stated above, 
studying the effects of oxygen availability on encapsulated islets can enhance our 
understanding of the functions of islets under hypoxic conditions. 
 To further understand how to improve bioartificial pancreas development, this 
thesis focuses on two aims: 1) characterizing PEGylated beads by stability and insulin 
diffusivity in order to refine the encapsulation material and 2) determining the effects of 
oxygen availability on the function of encapsulated adult porcine and neonatal porcince 
islets. For the first aim, the paper hypothesizes that PEGylating, or covalently binding 
poly(ethylene glycol) [PEG], the AP hydrogels will help reduce the fibrotic adhesion due 
to the steric hindrance effects of the PEG compound. In order to prevent fibrotic 
overgrowth, the PEG layer must be stable. However, to achieve the main goal of the 
bioartificial pancreas, the PEG layer should not affect the insulin diffusivity compared 
with AP capsules. The second aim studied the effects of oxygen availability on 
encapsulated islets to enhance our understanding of the functions of islets under hypoxic 
conditions. This experiment will look at total protein content as a relationship to protein 
synthesis, the ratio of insulin secretion to intracellular insulin content, and metabolic 




Aim 1: Characterizing PEGylated alginate/PLL bead for PEG stability and insulin 
diffusivity  
 
 Improvements to the encapsulation therapy can be done by changing the 
chemistry used for the beads.
4
 It is known that PEG can reduce immune response by 
preventing and displacing protein and cell adsorption to its surface. A previous study 
determined that PEG coated alginate capsules are highly biocompatible by themselves, 
however, their methodology was complex and we are seeking to develop a more 
straightforward method, which will be widely applicable.
16 
In this research, it is 
hypothesized that the PEG layer of Ca-LVM-PLL-PEG (AP-PEG) beads would be stable 
over time and that the PEGylation would not affect the diffusivity of small molecules 
within the capsules. 
 
Aim 2: Determining the effects of oxygen availability on the functions of 
encapsulated insulin-producing cells 
 
 In this paper, encapsulated APIs and NPIs will be cultured under 21% AS 
(normoxia) and 10% AS (hypoxia) to determine the effects of oxygen concentration on 
both types of islets. Since NPIs were found to be resistant to hypoxia, another set of NPIs 
will be cultured under normoxia and 1% AS (acute-hypoxia) to study the effects of 
different oxygen concentrations on NPIs. APIs were also introduced to a re-oxygenation 
process by exposing them to hypoxia for 7 of days and then bringing them back to 
normoxic conditions for 2 hours before sample collection; this will determine the time 
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point that effects by hypoxia is irreversible. All groups were evaluated on days 0, 7, and 







Aim 1: Characterizing PEGylated alginate/PLL bead for PEG stability and insulin 
diffusivity 
  
 Previous studies have tested a range of chemical structures for the encapsulation 
gel, but the primary encapsulation process has been focused on alginate beads. Since 
these beads adsorb and are permeable to IgG, they are unsuccessful in long-term stability. 
Other studies have tried combining different chemical structures like alginate and PLL 
and alginate-PLL-alginate (APA) beads to protect the islet cells, but proved to be 
unsuccessful. Researchers are now exploring PEG as a molecule to cover AP beads 
because of its steric hindrance properties to disrupt adsorption on surfaces. 
 Sawhney et al (1993) introduces a procedure to add a PEG-based hydrogel upon 
AP beads.
7 
However, this procedure is complicated and relies on expensive equipment. 
PEG can decrease the immune response of fibrous overgrowth by aiding in prevention of 
proteins or cells attachment to the surface. In this paper, FITC tagged PEG was used to 
quantify the duration of constant PEG density on the AP beads. Extended research should 
be done to understand and explore further chemical combinations of AP with PEG. 
 To further look into different chemistry combinations with PEG, this research will 
focus on the possibility of Ca-LVM-PLL beads for covalently bonding with PEG. In 
order to evaluate the potential of utilizing this PEG coating, two assays will be employed: 
PEG layer stability and insulin diffusivity. To demonstrate that the PEG layer does not 
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adversely affect the favorable characteristics of the alginate microcapsules, the capsules 
will be tested in vitro by themselves. At the end of this experiment, we will conclude 
whether this Ca-LVM-PLL-PEG hydrogel is a worthwhile delivery material to move 
forward with. 
 
Aim 2: Determining the effects of oxygen availability on the functions of 
encapsulated insulin-producing cells 
 
 Since the oxygen levels of the environment of the transplantation site is lower 
than that of the environment that they are extracted from, the function of the islets should 
be examined to observe the effects of varying oxygen levels. Hyder (1998) studied the 
effect of oxygen levels on insulin secretion of islet cells from the same species but 
different ages as well as islet cells of  different species. The primary cell type used in this 
study was rat islet cells. Neonatal and adult rat islets (ARIs) were exposed to 21% O2 
(normoxia) and 5% O2 (hypoxia) in basal and stimulated media to compare the effect of 
hypoxia on insulin secretion of different ages in different media environment. Results 
only showed that the insulin secretion of ARIs under hypoxia had a significant difference 
compared to ARIs in normoxic conditions for both basal and stimulated media. This 
suggests that islet cells of a younger age are more resistant to hypoxia.
12 
 Emamaullee (2006) examined the function of NPI under oxygen-induced stress. 
Insulin secretion and apoptosis were evaluated after NPIs and APIs were exposed to 
hypoxia and hypoxia/re-oxygenation conditions. Results showed that NPIs were more 
successful in resisting apoptosis and maintaining insulin secretion under both oxygen-
 12 
induced stress conditions. Islet grafts of both cell types were then transplanted into 
chemically diabetic, immune-deficient mice. Twenty-four hours after transplantation, 
API grafts experienced apoptosis while NPIs showed limited apoptosis. This suggests 
that NPIs are more resistant to hypoxia compared to APIs.
11 
 In order to increase our understanding of the effects of oxygen levels on porcine 
islets, this research will expand on the Hyder (1998) and Emmanuelle (2006) studies. 
This research will examine the effects of oxygen levels on insulin secretion, metabolic 
activity, intracellular insulin storage, and total protein content of NPIs and APIs. The 
functions of NPIs will be examined at three different oxygen levels (normoxia, hypoxia, 
acute hypoxia), meanwhile APIs will be examined at three different oxygen conditions 
(normoxia, hypoxia, reoxygenation).At the end of this experiment, we will receive a 






AIM 1: CHARACTERIZING PEGYLATED ALGINATE/PLL BEAD 




 To determine the effect of PEG reaction concentration on the resulting 
PEGylation of Ca-LVM-PLL capsules, and evaluate the stability of the PEG layer in vitro  
Protocol 
 This experiment tested the bonding of FITC-PEG to the Ca-LVM beads by a 
concentration range. PEG capsules tested are cross-linked with PLL coated Ca-LVM 
alginate beads (AP-PEG beads).  There were three experimental groups: 1mM AP-PEG 
beads, 0.5mM AP-PEG beads, and 0.05mM AP-PEG beads. The two control groups 
served for different reasons: the 0mM AP-PEG beads showed any background 
fluorescence emitted by the beads itself, and the 1mM A-PEG (PLL uncoated) beads 
showed us any non-specific adsorption. Under sterile environment, 100 L of beads were 
distributed into a well of a 24 non-treated well plate and the respective FITC-PEG 
(Nanocs) concentrations were added with the lights off, since FITC is sensitive to light. 
The beads were incubated with the FITC-PEG for 30 minutes on a plate shaker. The 
beads were then washed three times every fifteen minutes for ten washes with 6 mL of 
calcium chloride to get rid of any excess FITC-PEG. Before each time point, 200 L of 
the surrounding calcium chloride solution were transferred into a black 96 non-treated 
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well plate for reading. After the collection, the old solution was replaced with 1 mL of 
new calcium chloride. Fluorescent area scans and solution readings were done at day: 0, 
1, 2, 3, 4, 5, 7, 8, 11, 14, 18, 21, 25, 28, 32, and 35. For the area scans, the plate reader 
was set to read from the bottom of the plate with excitation of 495 and emission of 525, 
and a gain of 125. The settings were kept the same for the solution readings except it was 
done from the top of the plate. The data is later evaluated for any trends. To validate the 
stable hypothesis, the area scans should stay constant throughout, to show that the density 
of PEG does not decrease and the PEG is not breaking off. A paired student’s t-test was 
used to determine statistical significance between the first and last data points of the area 
scans. Furthermore, the solution readings should move towards zero to show diffusion of 
FITC-PEG inside the beads to their surrounding has stopped. There should also be a 
relationship between the concentration of FITC-PEG and the fluorescent values: the 
higher the concentration, the higher the fluorescence. 
Diffusivity Test 
Purpose 
 Determine insulin diffusivity in PEGylated capsules compared with APA and Ca-
LVM capsules  
Protocol 
 This experiment compared the diffusivity coefficients of linear and branched 
PEGylated beads to that of Ca-LVM and APA beads. The difference between the two 
PEG molecules is the size; the branched PEG has a higher molecular weight compared to 
the linear PEG.
17
 Both PEG types were tested to ensure that the molecule does not affect 
insulin diffusivity, not just a specific size. 100 L of CA-LVM beads were distributed 
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into a well of a 24 non-treated well plate via strainer.  The strainer was moved into 
another well and the solution the beads were sitting in was replaced with 400 L of 16.6 
mg/mL bovine insulin. The plate was placed on a shaker for one hour to ensure the beads 
have reached equilibrium with its surrounding. The strainer was then transferred to 
another well plate before removing the insulin. The beads were quickly washed twice by 
dunking the strainer in 1 mL of unsupplemented media (8.3 g/L Dulbecco's modified 
Eagle's medium (DMEM D5030; Sigma) supplemented with 3.7 g/L sodium bicarbonate 
(NaHCO3; Sigma), and 0.9008 g/L of D-glucose (Sigma)) in the adjacent two wells, and 
the strainer will be left in the third well with 1 mL of unsupplemented media. A 10 L 
sample of the surrounding solution will be taken at minute: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 
20, 30, 40, 50, and 60. Procedure will be replicated for the APA and PEGylated beads. 
After all collection, 10 L of each standard was placed in the next column(s) of wells. 
300 L of room temperature Coomassie solution was added to every well. After 30 
seconds on the shaker, the plate was left to settle for 10 minutes. The absorbance reading 
of the solutions should be done after the 10 minutes and before 30 minutes since adding 
Coomassie solution. The data was then plotted and the diffusivity coefficients of both 
beads were calculated from the following modeling equation from Sambanis (1999): 
- 
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 Equation describes diffusion of solute from beads into the liquid bulk, 
initially containing no solute. 
 In the equation above, Cb is the concentration of insulin at a given time in 
the bulk solution (mol/m
3
); Cbo is the initial concentration of insulin within 
the bulk solution (mol/m
3
); α is the ratio of liquid volume to total bead 
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volume; Deff is the effective diffusivity (m
2
/s); R is the bead radius (m), qn 
is the nth root of the equation
18
 
The coefficients should be comparable between the beads to justify the hypothesis that 
PEG does not affect the diffusivity of AP beads.
9
 A one way ANOVA with a p-value of 
0.05 was used to determine if there were any statistically significant differences between 
the groups of beads.  
Results 
Stability Test 
 The stability of the PEG coating on AP beads were determined by analyzing the 
trends of the fluorescent readings of the surrounding solution and area scans of the beads. 
Figure A.1 shows the calcium chloride solution readings had a general decrease and bead 
fluorescence did not decline for both the experimental groups and control throughout the 
duration of the experiment. The relative fluorescence unit (RFU) of the calcium chloride 
solution reading for each group declined over time, but it does appear that some FITC-
PEG is found in solution for several of the groups throughout the course of the 
experiment. Since there is huge difference in magnitude for the RFU in solution and the 
RFU in area scans, having a few FITC-PEG in the solution does not make the PEG layer 




Figure A.1: Fluorescent solution readings and area scans of all groups at 
predetermined time points. The experiment tested three different concentrations groups 
against two controls. Average fluorescence of the area scans was recorded in order to 
quantify the amount of PEG density on the surface of the Ca-LVM beads. Solution 
readings were recorded to observe the amount of FITC-PEG diffusing from inside the 
beads into the solution surrounding the beads. The fluorescence of both solution readings 
and area scans are used to determine the stability of the beads by tracking them over time. 
Errors bars show standard deviation between n=2 groups. 
 
 The FITC-PEG fluorescence readings show a relationship between the 
concentration of FITC-PEG and fluorescence; the higher the concentration, the higher the 
fluorescence. As the reaction concentration of FITC-PEG increases, so does the RFU of 
the beads, indicating that a greater density of PEG was grafted onto the surface. Shown as 
a negligible RFU in the 1mM A-PEG, the data suggest that PEG bonds with the PLL 
layer. As seen in Figure A.1, the fluorescent readings for all groups stayed consistent 
throughout the 35-day duration, meaning that the PEG layer was bonded to the AP beads 
for the entire experiment. Since the AP beads did not lose anymore PEG for 35 days and 
the PEG layer stay bonded to the AP beads for that time span, the PEG layer can be 
concluded as stable for the duration of the experiment. To statistically determine 
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significant results, a student’s t-test was used for the first and last data point for each 
group. A p-value of 0.2208 was obtained, showing no statistical significant difference 
between the RFU at the beginning and end of the experiment. 
Insulin diffusivity  
 The diffusivity of the Ca-LVM, APA, linear PEG and branched PEG beads were 
determined by comparing the calculated and measured diffusivity coefficients of the 
beads. Figure A.2 shows the diffusivity coefficients of all four bead groups. The 
diffusivity coefficients were calculated for each trial individually using the equation 
provided by Sambanis (1999) and then the average of each group is graphed in figure 
A.2. The results show that diffusivity coefficients are similar for all four hydrogel 
materials. Using a one-way ANOVA, a p-value of 0.786322 was calculated, confirming 




Figure A.2: Diffusivity coefficients of different hydrogels. Different hydrogels were 

































transfer of the beads into solution containing no insulin, samples of the solution were 
collected at various time points and the concentration of insulin was analyzed. Using the 
equation in Sambanis (1999), diffusivity coefficients for each group was calculated. The 
average diffusivity coefficients are shown above. *Bars indicate standard deviation 




 Based on Figure A.1, the solution readings display a general decrease in RFU 
within all groups. The decreasing trend shows that the amount of FITC-PEG inside of the 
bead is lessening. The average bead fluorescence displays a correlation between 
concentrations of FITC-PEG to RFU expression. The 0mM AP-PEG beads were used as 
a control to detect any background fluorescence, while the 1mM A-PEG beads were set 
to observe non-specific adsorption. Since both controls have statistically similar RFUs 
and therefore we can conclude that minimal non-specific adsorption occurred. With the 
straight line trends in average bead fluorescence and decreasing solution readings, 
PEGylated AP beads are determined to be stable within the 35-day time frame of the 
experiment. 
 The data in Figure A.2 shows that both linear and branched PEGylated beads have 
similar diffusivity coefficients as compared to Ca-LVM and APA beads. A one way 
ANOVA was used to determine if there were any statistically significant differences 
between the diffusivity coefficients of all groups of beads. After calculations, a p-value of 
0.786322 obtained, showing no statistically significant differences between the 
diffusivity coefficients. This confirms that the insulin diffusivities of linear and branched 
PEG are comparable to Ca-LVM and APA diffusivities in already published findings, 
and PEG did not hinder the insulin diffusivities of these beads.
19 
 20 
 Similar to Sawhney et al (1993), this experiment has successfully PEGylated AP-
beads. The difference between the two experiments derives from the method used to 
PEGylate beads, this project simply crosslink PEG to the surface of AP beads, whiles 
Sawhney et al (1993) utilizes photopolymerization, a difficult method requiring 
expensive equipment. The PEG layer is found to be stable over a 35-day period and 
generally does not affect the insulin diffusivity of the AP beads. In order to introduce 
PEGylated beads as an encapsulation material, they must be tested to see if they elicit an 
immune response that may lead to islet cell death. Sawhney et al (1993) found that 
PEGylated beads are less likely to elicit an immune response than AP beads. Since 
insulin diffusivity was not evaluated in previous studies, these results are important as a 
deciding factor for PEGylated beads as an encapsulation material. Furthermore, the 
stability of these beads will determine the duration that PEGylated beads can function as 







AIM 2: DETERMINING THE EFFECTS OF OXYGEN 





 To study the effects of oxygen availability on different cell types, NPIs and APIs 
were encapsulated separately in Ba-LVM, alginate that is solubilized easier than Ca-
LVM, capsules and exposed to a hypoxia level of 10% AS.  Each cell type had a 
normoxic (21% AS) group to represent as the control at each time-point. On the other 
hand, to study the effects of different levels of oxygen availability, another group of NPIs 
were exposed to 1% AS and had a normoxic control group for each time-point. APIs 
were also subjected to a reoxygenatiom process, placing them in hypoxic conditions for 7 
days then normoxic conditions for 2 hours before collecting samples. This was done to 
study the response of API functions after a traumatic exposure. All groups (hypoxic and 
normoxic) associated with the 10% AS were evaluated for insulin secretion, metabolic 
activity, intracellular insulin storage, and total protein content on days 0, 7, and 14. The 
normoxic and hypoxic groups related to the 1% AS were evaluated for the 
aforementioned parameters on days 0, 7, and 15.  
 During the study, samples were collected at the time-points and placed in -80C 
until assays and micro-plate readings were performed. Hypoxic groups also received 
media and HBSS that was placed in respective oxygen levels at least 24h prior to use to 
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allow solutions to acclimate to the hypoxic levels. An alamarBlue protocol and 
fluorescence readings were used to determine the metabolic activity of the encapsulated 
cells. On the days of evaluation, beads were given fresh media and alamarBlue reagent 
was added to the wells at a 1:9 dilution of reagent to media for a 2h incubation period. 
Samples for the metabolic activity test were collected after the incubation period in 
respective oxygen levels then the beads were washed with HBSS. After receiving new 
media, a t=0 sample was collected for the insulin secretion test. After a two hour 
incubation in respective oxygen levels, a t=2 sample was collected. The concentration of 
secreted insulin was determined using a porcine insulin ELISA kit and was calculated by 
subtracting the initial quantity of insulin from the final quantity of insulin.  
 When all samples for insulin secretion have been collected, beads were 
solubilized and cell pellets were collected through centrifugation. Cells were then lysed 
with mammalian cell lysis buffer to perform assays for total protein content and 
intracellular insulin storage. Total protein content samples were prepared using a Micro 
BCA protein assay kit and absorbance readings were taken to determine the quantity of 
protein inside the cells. The porcine insulin ELISA kit above was also used to quantify 
the amount of insulin in the intracellular storage through fluorescence readings.   
 General trends of each function were observed to access the effects of oxygen on 
islet functions. For easier understanding, insulin secretion and intracellular insulin storage 
will be represented as the ratio of insulin secretion to intracellular insulin content. This 
means that the data will denote percent of insulin secreted compared to the amount of 
insulin stored inside the beads. Since this is the first time this experiment has been done, 




 Neonatal porcine islets were exposed to 1% and 10% AS oxygen levels, while 
adult porcine islets were exposed to 10% AS oxygen. Parameters of total protein content, 
secretion percentage, and metabolic activity of each hypoxic islet group and its normoxic 
counterpart were measured. Figure B.1 shows the data that was collected from the total 
protein assays with results graphed as quantity of protein.  The secretion to storage ratio 
percentage of each group was calculated by: 
                 
                             
       and is 
shown in Figure B.2. The metabolic activity of the islets were also tracked and graphed in 
Figure B.3. The general trends of each function parameters will be compared between 
groups, this result analysis will not investigate the trends within an individual group. To 
determine the effect of hypoxia on the functions of different cell types, the parameters of 
the NPIs and APIs exposed to 10% AS should be compared. Similarly, to determine the 
effect of different levels of hypoxia on the functions of the same cell type, the parameters 
of both the NPIs exposed to 1% and 10% AS should be compared.   
 Since the two are from the same group, and their normoxic groups were exposed 
to the same condition, the data suggests that the number of cells encapsulated in the NPIs 
at 1% AS may have been lower than that of the 10% or there possibly might be another 
factor that cannot be determined by this data alone. APIs, on the other hand, shows a 
200% increase of total protein content compared to NPIs exposed to the same condition. 
Since the hypoxic groups of the NPIs show similar results as their normoxic counterparts, 
total protein content of NPIs seem to not be affected by the different level of oxygen. 
However, the total protein content for hypoxic and reoxygenated groups of the APIs is 
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reduced, and therefore affected by the oxygen level. Furthermore, these two groups of the 
APIs are similar, meaning that total protein content of APIs is comparable for different 
oxygen-induced stress conditions. 
 
Figure B.1: Effect of hypoxia on total protein content of encapsulated porcine islets. 
Encapsulated NPIs and APIs were exposed to different levels of hypoxia. Total protein 
content samples were collected at three time points and analyzed using a Micro BCA 
total protein assay kit.  
 
 As seen in Figure B.2, the normoxic groups of both cell types secrete around the 
same percentage of insulin. For the data is missing for the NPIs exposed to 1% AS, 
possibly resulting from error in cell pellet collection. The NPIs exposed to 10% AS 
shows an increase in insulin secretion percentage to 140% . This suggests that the islets 
secreted all of its intracellular insulin content and more. Since this data was collected for 
the first time, this data point shows a source of possible error. However, APIs exposed to 
10% AS also showed an increase in insulin secretion ratio. Based on the data presented, it 
is unclear whether this increase was due to an increase of insulin secretion or a decrease 
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Figure B.2: Effect of hypoxia on the ratio of insulin secretion to intracellular insulin 
content. Encapsulated NPIs and APIs were exposed to different levels of hypoxia. Ratio 
was determined by dividing insulin secretion by intracellular insulin storage, value was 
multiplied by 100 to convert into percentage.  
 
 Shown below in Figure B.3 is the metabolic activity of the encapsulated cells 
exposed to different levels of oxygen over time. NPIs exposed to 1% AS and its 
normoxic group had a metabolic activity of around 50% of the NPIs exposed to 10% AS 
and its normoxic group. Similarly to the total protein content data, this suggests that the 
number of cells encapsulated in the NPIs at 1% AS may have been lower than that of the 
10% or there possibly might be another factor that cannot be determined by this data 
alone. When comparing the metabolic activity of same islets under different levels of 
oxygen, NPIs exposed to hypoxia shows a general 50% decrease compared to their 
normoxic counterparts, therefore metabolic activity of  NPIs seem be affected by the 
different level of oxygen. Under normoxia, APIs have a metabolic activity that is 
generally twice that of the normoxic group of NPIs exposed to the same hypoxic 
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for hypoxic and reoxygenated groups of the APIs are reduced by half of its normoxic 
counterpart, and are affected by the oxygen level. Furthermore, these two groups of the 
APIs are similar, meaning that metabolic activity of APIs is comparable for different 
oxygen-induced stress conditions. 
  
 
Figure B.3: Effects of hypoxia on metabolic activity. Encapsulated NPIs and APIs 
were exposed to different levels of hypoxia. Metabolic activity was determined by 






 Since this experiment has only been done once, these results should be viewed as 
preliminary and may be used to inform the design of future studies. To see statistically 
significant results from this experiment, it must be repeated a minimum of 2 additional 
times. Furthermore, this data is incomplete, as seen in the intracellular insulin storage 
results for NPIs exposed to 1%AS. The hypoxic data is at zero for all time-points, 
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Based on the parameters of total protein content, secretion percentage, and 
metabolic activity, our preliminary data suggests several things about the functions of 
islets exposed to different levels of oxygen. The first is that only the total protein content 
of APIs is affected by different levels of oxygen, possibly indicating that the oxygen has 
an effect on protein synthesis for APIs. The second suggestion is that islets of both ages 
may secrete more insulin compared to its intracellular insulin content when under an 
oxygen-induced stress condition (hypoxia or reoxygenation). This can be that these cells 
are not producing enough insulin to restore its intracellular content, or the cells are no 
longer responding properly to physiological cues. The reader must keep in mind that this 
suggestion was made without data for NPIs exposed to acute hypoxia. Third, the 
metabolic activity of all three experimental groups show around a 50% decrease, 
statistical analysis may be required to show which group’s metabolic activity was more 
affected by the oxygen levels. Fourth, our data suggests that functions of APIs respond 
similarly for different oxygen-induced stress conditions. 
There are currently little published findings on the effects of hypoxia on neonatal 
porcine islets. However, this study is similar to that of Hyder (1998), in that it compares 
the effects of hypoxia on islet cells of the same species at different ages but this study 
goes further in trying to determine the effects of different levels of hypoxia on islets. 
Although, the other paper tested the effects of hypoxia on functions of rat islet, both 
papers suggest that functions of neonatal islets are less affected by low levels of oxygen. 
This conclusion is reaffirmed by Emamaullee (2006) demonstrating that NPIs have a 
natural resistance to hypoxic environments. Overall, this confirms that NPIs may be the 
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preferred cell type for the encapsulation method, due to higher stability of functions 
under hypoxic conditions.  
Even though the functions NPIs are concluded to be less affected by hypoxia, 
NPIs will eventually mature and develop in APIs, it is possible that they may become less 
resistant to hypoxia. This means that NPIs will only be resistant to hypoxia before they 
reach maturity. As mentioned before, NPIs also require several weeks to function post-
transplantation when compare to APIs, cutting down the time span that hypoxia-resistant 




 As research expands to provide a superior treatment for insulin-dependent 
diabetes, cell-based insulin therapies continue to be the most widely sought after insulin 
delivery method. To further improve this method, new encapsulation chemistry should be 
tested for its stability and insulin diffusivity. The results in this experiment show that 
PEG is stable for 35-days and does not affect the insulin diffusivity of AP beads. These 
results also showed that there were negligible fluorescent readings for PEG over the 35-
day time period when the beads were not coated with PLL, suggesting that PEG 
covalently bonds to the PLL layer of AP beads. 
 Further research on the second aim will improve our understanding of the effects 
of low levels of oxygen on the encapsulated insulin-producing cells. These preliminary 
results showed that lower levels of oxygen had a greater affect on islet functions of total 
protein content, insulin secretion, intracellular insulin storage, and metabolic activity. 
They also suggest that NPI functions are more resistant to hypoxia than APIs, similar to 
published conclusions. Using this information, researchers can develop strategies to help 




Aim 1: Characterizing PEGylated beads by stability and insulin diffusivity in order 
to refine the encapsulation therapy 
 
 To further characterize the PEGylated AP capsules, additional experiments need 
to be performed including assessment of the permeability of the PEG to specific 
molecules like IgG, assessment of the cytotoxicity of the PEGylation procedure, and in 
vivo evaluation of the capsule. Permeability defines the types of molecules that can be 
exchanged in and out of the beads, which can be targeted for wanted molecules or help 
prevent unwanted ones. To make sure the encapsulation material does not kill the cells 
inside, the cytotoxicity assay determines if the material will affect the viability of 
encapsulated cells. To quantify the amount of cells adsorption, histology can identify the 
fibrotic density on the surface of the beads. 
 In the permeability assay similar to Kulseng (1997), AP-PEG capsules should be 
exposed to IgG to conclude whether the PEG layer allows for IgG permeation and if PEG 
affects the permeability of the AP beads. Histology of the adsorption on the surface of 
AP-PEG beads can be done by exposing the beads to cells and then staining to quantify 
the amount of cells attracted to the surface of the beads. The last assay will use the 
metabolic activity of the islets to determine survival rate of encapsulated cells in the 
beads, subsequently determining cytotoxicity of the PEGylation process. 
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Aim 2: Determining the effects of oxygen availability on the functions of 
encapsulated insulin-producing cells 
 
 A major improvement to this experiment is during the cell pellet collection 
process to ensure that all data points are present. As discussed in Chapter 4, if statistically 
significant results are desired, this experiment should be repeated a minimum of 2 
additional times. However, the goal of obtaining preliminary results for this experiment 
has been achieved, and the experiment is completed, therefore future work will not be 
planned. Continuing this work will better the understanding of the effects of oxygen 
levels on islet functions. Since the peritoneal cavity is an appealing site for 
transplantation, furthering this research will give insight on how to improve the 
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